ArticleArchives of toxicology2024

TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2

Xinyi Shao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.